Sílvia Coma
Impact in
Papers in
-
- Melanoma and MAPK Pathways 7
- Angiogenesis and VEGF in Cancer 4
- Oncology 15
- Co-authors
- Michael Klagsbrun (6 shared papers)Akio Shimizu (3 shared papers)Jonathan A. Pachter (19 shared papers)Tomoshige Akino (2 shared papers)Akiko Mammoto (2 shared papers)Hironao Nakayama (2 shared papers)Elisa Boscolo (1 shared paper)Matthew L. Warman (1 shared paper)
- Journals
- Cancer Research (12 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Scientific Reports (2 papers)Angiogenesis (2 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Sílvia Coma
35 papers receiving 845 citations
Peers
Comparison fields: 5 of 74
- Oncology 276
- Genetics 85
- Cellular and Molecular Neuroscience 141
- Immunology 162
- Cancer Research 111
Countries citing papers authored by Sílvia Coma
This map shows the geographic impact of Sílvia Coma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sílvia Coma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sílvia Coma more than expected).
Fields of papers citing papers by Sílvia Coma
This network shows the impact of papers produced by Sílvia Coma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sílvia Coma. The network helps show where Sílvia Coma may publish in the future.
Co-authors
The 25 scholars most cited alongside Sílvia Coma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 94 | |
| 2 | 2022 | 91 | |
| 3 | 2012 | 87 | |
| 4 | 2013 | 83 | |
| 5 | 2010 | 70 | |
| 6 | 2004 | 56 | |
| 7 | 2016 | 55 | |
| 8 | 2021 | 54 | |
| 9 | 2011 | 49 | |
| 10 | 2015 | 45 | |
| 11 | 2013 | 40 | |
| 12 | 2022 | 27 | |
| 13 | 2021 | 24 | |
| 14 | 2024 | 11 | |
| 15 | 2025 | 11 | |
| 16 | 2002 | 9 | |
| 17 | 2016 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 1987 | 5 |
About Sílvia Coma
Sílvia Coma is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 38 papers that have together received 857 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Mechanisms and Therapy (5 papers), Immune Cell Function and Interaction (4 papers), Axon Guidance and Neuronal Signaling (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (3 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Oncology (276 citations), Genetics (85 citations), Cellular and Molecular Neuroscience (141 citations), Immunology (162 citations) and Cancer Research (111 citations). Sílvia Coma has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Michael Klagsbrun, Akio Shimizu, Jonathan A. Pachter, Tomoshige Akino, Akiko Mammoto, Hironao Nakayama, Elisa Boscolo, Matthew L. Warman, Joyce Bischoff and Carlos J. Ciudad. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, Scientific Reports and Angiogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.